Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGH
2001
DELISTED
Textainer Group Holdings limited
TGH
| $10M | ﹤0.01% |
296,831
-16,116
| -5% | -$476K |
|
2002
Seres Therapeutics
MCRB
$46.8M
| $10M | ﹤0.01% |
21,008
+1,889
| +10% | +$797K |
|
2003
Addus HomeCare
ADUS
$2.16B
| $10M | ﹤0.01% |
114,675
+9,028
| +9% | +$878K |
|
2004
PureCycle Technologies
PCT
$1.28B
| $10M | ﹤0.01% |
+422,814
| New | +$9.1M |
|
|
VCRA
2005
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $10M | ﹤0.01% |
250,883
+29,547
| +13% | +$1.08M |
|
2006
Liberty Broadband Class A
LBRDA
$4.89B
| $9.97M | ﹤0.01% |
59,285
+507
| +0.9% | +$79.3K |
|
|
SHOE
2007
Shoe Station Group
SHOE
$413M
| $9.95M | ﹤0.01% |
277,956
-12,784
| -4% | -$414K |
|
2008
Butterfly Network
BFLY
$1.89B
| $9.9M | ﹤0.01% |
+683,820
| New | +$9.23M |
|
2009
Heron Therapeutics
HRTX
$93.9M
| $9.89M | ﹤0.01% |
637,446
+67,835
| +12% | +$1.08M |
|
|
EB
2010
DELISTED
Eventbrite
EB
| $9.88M | ﹤0.01% |
519,857
+58,254
| +13% | +$1.24M |
|
2011
Middlesex Water
MSEX
$1.08B
| $9.87M | ﹤0.01% |
120,782
+2,023
| +2% | +$167K |
|
2012
Agilysys
AGYS
$2.97B
| $9.85M | ﹤0.01% |
173,243
+2,335
| +1% | +$121K |
|
2013
St. Joe Company
JOE
$3.54B
| $9.83M | ﹤0.01% |
220,346
+3,496
| +2% | +$158K |
|
2014
XPEL
XPEL
$1.22B
| $9.82M | ﹤0.01% |
117,144
+3,969
| +4% | +$293K |
|
2015
nLIGHT
LASR
$3.88B
| $9.82M | ﹤0.01% |
270,698
+19,697
| +8% | +$588K |
|
2016
Castle Biosciences
CSTL
$855M
| $9.77M | ﹤0.01% |
133,253
+16,606
| +14% | +$1.1M |
|
|
FARO
2017
DELISTED
Faro Technologies
FARO
| $9.77M | ﹤0.01% |
125,639
+3,118
| +3% | +$246K |
|
2018
Enterprise Financial Services Corp
EFSC
$2.4B
| $9.77M | ﹤0.01% |
210,534
+12,915
| +7% | +$632K |
|
2019
Interparfums
IPAR
$3.99B
| $9.77M | ﹤0.01% |
135,649
+9,015
| +7% | +$665K |
|
2020
Koppers
KOP
$943M
| $9.73M | ﹤0.01% |
300,881
-8,430
| -3% | -$284K |
|
2021
Helix Energy Solutions
HLX
$1.4B
| $9.72M | ﹤0.01% |
1,703,028
-43,699
| -3% | -$230K |
|
|
NEX
2022
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $9.71M | ﹤0.01% |
2,039,031
+146,038
| +8% | +$641K |
|
2023
World Acceptance Corp
WRLD
$838M
| $9.7M | ﹤0.01% |
60,541
-4,097
| -6% | -$600K |
|
2024
Quanex
NX
$819M
| $9.67M | ﹤0.01% |
389,332
-6,827
| -2% | -$182K |
|
|
IMGN
2025
DELISTED
Immunogen Inc
IMGN
| $9.64M | ﹤0.01% |
1,462,235
+24,635
| +2% | +$172K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.